Drawing for CLOVINOL

USPTO serial 90462894

CLOVINOL

Reviewed by CopyMark Law Group

Reg. 6455788Status 700Renewal
Filing date
Status date
Registration date
Aug 17, 2021
Examiner
CHIANG, TIFFANY YOUNG

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Deadline: August 17th, 2027

Need help with CLOVINOL?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

Owner

  • Akay USA LLC

    Sayreville, NJ, US

  • Akay USA LLC

    Sayreville, NJ, US

  • Akay USA LLC

    Sayreville, NJ, US

Goods and services

ClassDescriptionStatusFirst use
005Dietary supplement containing clove extractACTIVEApr 8, 2013

Prosecution history

DateCodeEventWhat it means
Aug 17, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 17, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 1, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 1, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 12, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 28, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Apr 27, 2021DOCKASSIGNED TO EXAMINER
Apr 13, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Frequently asked questions

Related guidance